세계의 인공호흡기 시장 예측(-2029년) : 가동성별, 유형별, 인터페이스별, 방식별, 케어 환경별

The ventilators market is projected to reach USD 4.66 Billion by 2029 from USD 3.71 Billion in 2024 at a CAGR of 4.7% during the forecast period.

Increscent respiratory illnesses like COPD and asthma are key drivers of the ventilators market. With growing air pollution levels, lifestyles, and ageing populations, an increased number of these chronic ailments have resulted in more frequent and severe respiratory attacks. COPD and severe asthma patients frequently need respiratory support through acute exacerbation, increasing hospital and homecare demand for both invasive and non-invasive ventilators. Further, ongoing advancements in ventilator technology-safety, accuracy, and patient outcomes-prompt healthcare professionals to invest in newer respiratory support equipment. In sum, the increasing burden of respiratory illnesses is driving market growth.

"The High-end ICU ventilators segment is accounted for the largest share of global ventilators market."

Premium ICU ventilators have the largest market share of the worldwide ventilators market due to the fact that they are essential in the treatment of life-threatening situations in intensive care units. Such high-end equipment has a comprehensive variety of ventilation modes, advanced monitoring systems, and improved safety features that are necessary for critical patients. With the aging worldwide population and prevalence of sophisticated respiratory diseases, healthcare facilities are aggressively investing in next-generation ICU solutions. In addition, ongoing development and strict standards imposed by regulative bodies support the use of these advanced devices, making them the go-to option in life-critical applications where the utmost patient outcomes must be achieved.

"Combined mode ventilation has the largest market share in ventilators market."

Combined mode ventilators command the highest market share in the ventilators segment due to the fact that they provide the most advantageous aspects of volume- and pressure-controlled ventilation, allowing clinicians to customize respiratory support to the individual needs of a patient. The products allow clinicians to accurately control tidal volumes while also limiting pressure so that the lungs are not injured, thereby giving a versatile solution that can work in a number of clinical circumstances. Their paired, high-tech monitoring systems and automated adjustments do not only add convenience but also improve patient results. Accordingly, combined mode ventilators are in great demand among intensive care units with critically ill patients who need dynamic and flexible modes of ventilation. In addition, unbroken technology innovation, increased spending on healthcare facilities, and increasing instances of respiratory diseases have each played a role to drive combined mode ventilators to the top of the market.

"Europe holds the second largest market share in the ventilators market."

Europe is the world's second-largest ventilator market, with its established healthcare infrastructure, heavy government spending, and stringent regulation that guarantees top-quality products. Extensive coverage of intensive care units and hospitals in Europe, combined with high incidence of respiratory conditions and the ageing population, all ensure rising demand for invasive as well as non-invasive ventilators.

Moreover, Europe is favored with a vibrant community of top-notch producers and never-ending innovation, leading to the development of ultra-modern technologies that improve patient results. Together with forward-looking healthcare measures and all-encompassing insurance coverage, Europe is a strong market for ventilators worldwide, guaranteeing its position as the second largest market share holder.

A breakdown of the primary participants (supply-side) for the ventilators market referred to for this report is provided below:

• By Company Type: Tier 1-25%, Tier 2-40%, and Tier 3-35%
• By Designation: C-level-20%, Director Level-38%, and Others-40%
• By Region: North America-37%, Europe-28%, Asia Pacific-26%, Latin America- 6%, and Middle East and Africa- 1% and GCC Countries- 2%

Prominent players in this market include ResMed (US), Getinge AB (Sweden), Koninklijke Philips N.V. (Netherlands), Dragerwerk AG & CO. KGAA (Germany), ICU Medical, Inc. (US), Asahi Kasei Corporation (Japan), Air Liquide (France), Flexicare (Group) Limited (UK), Nihon Kohden Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd, (China), GE Healthcare (US), Baxter (US), Vyaire Medical, Inc. (US), Hamilton Medical (Switzerland), Skanray Technologies (India), aXcent Medical GmbH (Germany), Metran Co., Ltd (Japan), MAGNAMED (Brazil), Leistung Ingenieria SRL (Argentina), Avasarala Technologies Limited (India), Airon Corporation (Florida), TRITON Electronic Systems Ltd. (Russia), Bio-Med Devices, Inc. (US), HEYER Medical AG (Germany) and AgVa Healthcare (India).

Research Coverage:

The market study covers the ventilators market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by type, age group, interface, mode, care setting and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of Market Dynamics: Drivers (Rise in respiratory diseases

Urbanization and rising pollution levels, Rising obesity due to sedentary lifestyles, Growing geriatric population worldwide, Increasing preference for home care settings, Rising number of preterm births, Outbreak of infectious respiratory diseases) restraints (Shortage of skilled medical workers, Excessive purchase of ventilators during COVID-19, Reimbursement concerns) opportunities (Cost-efficiency of home care services, growth opportunities in emerging economies), and challenges (Low awareness and inadequate resources in emerging economies, Harmful effects of respiratory devices on neonates, Supply chain disruptions, Global demand fluctuations)

• Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the ventilators market.
• Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, care settings, and region.
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the ventilators market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the ventilators market like ResMed (US), Getinge AB (Sweden), Koninklijke Philips N.V. (Netherlands), Dragerwerk AG & CO. KGAA (Germany), and ICU Medical, Inc. (US).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED & REGIONS CONSIDERED
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES
• 1.6 IMPACT OF AI/GEN AI

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY RESEARCH
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY RESEARCH
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS
  • 2.5.1 SCOPE-RELATED LIMITATIONS
  • 2.5.2 METHODOLOGY-RELATED LIMITATIONS
• 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 VENTILATORS MARKET OVERVIEW
• 4.2 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE AND COUNTRY (2024)
• 4.3 VENTILATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 VENTILATORS MARKET: REGIONAL MIX
• 4.5 VENTILATORS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rise in respiratory diseases
      • 5.2.1.1.1 Increasing incidences of COPD and asthma
      • 5.2.1.1.2 High prevalence of tobacco smoking
    • 5.2.1.2 Urbanization and rising pollution levels
    • 5.2.1.3 Rising obesity due to sedentary lifestyles
    • 5.2.1.4 Growing geriatric population worldwide
    • 5.2.1.5 Increasing preference for home care settings
    • 5.2.1.6 Rising number of preterm births
    • 5.2.1.7 Outbreak of infectious respiratory diseases
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Shortage of skilled medical workers
    • 5.2.2.2 Excessive purchase of ventilators during COVID-19
    • 5.2.2.3 Reimbursement concerns
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Cost-efficiency of home care services
    • 5.2.3.2 Growth opportunities in emerging economies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Low awareness and inadequate resources in emerging economies
    • 5.2.4.2 Harmful effects of respiratory devices on neonates
    • 5.2.4.3 Supply chain disruptions
    • 5.2.4.4 Global demand fluctuations
• 5.3 INDUSTRY TRENDS
  • 5.3.1 RISING DEMAND FOR ENHANCED PORTABLE VENTILATORS
  • 5.3.2 MARKET CONSOLIDATION
  • 5.3.3 GROWING DEMAND FOR MULTIMODAL VENTILATORS
  • 5.3.4 INCREASING ADOPTION OF NON-INVASIVE VENTILATORS
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Sensor technologies
      • 5.4.1.1.1 Flow sensors
      • 5.4.1.1.2 Oxygen sensors
      • 5.4.1.1.3 Pressure sensors
  • 5.4.2 COMPLEMENTARY TECHNOLOGIES
    • 5.4.2.1 E-nose technology
    • 5.4.2.2 MEMS technology
    • 5.4.2.3 Electrochemical technology
    • 5.4.2.4 Paramagnetic technology
    • 5.4.2.5 Wireless gas sensor technology
  • 5.4.3 ADJACENT TECHNOLOGIES
    • 5.4.3.1 High-flow nasal cannula (HFNC) devices
• 5.5 PRICING ANALYSIS
  • 5.5.1 INDICATIVE PRICING OF VENTILATORS, BY KEY PLAYER
  • 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 SUPPLY CHAIN ANALYSIS
• 5.9 PORTER'S FIVE FORCES ANALYSIS
  • 5.9.1 THREAT OF NEW ENTRANTS
  • 5.9.2 THREAT OF SUBSTITUTES
  • 5.9.3 BARGAINING POWER OF SUPPLIERS
  • 5.9.4 BARGAINING POWER OF BUYERS
  • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.10.2 BUYING CRITERIA
• 5.11 REGULATORY ANALYSIS
  • 5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11.2 REGULATORY FRAMEWORK
    • 5.11.2.1 North America
      • 5.11.2.1.1 US
      • 5.11.2.1.2 Canada
    • 5.11.2.2 Europe
    • 5.11.2.3 Asia Pacific
      • 5.11.2.3.1 Japan
      • 5.11.2.3.2 China
      • 5.11.2.3.3 India
      • 5.11.2.3.4 South Korea
    • 5.11.2.4 Latin America
      • 5.11.2.4.1 Brazil
      • 5.11.2.4.2 Mexico
    • 5.11.2.5 Middle East
    • 5.11.2.6 Africa
• 5.12 PATENT ANALYSIS
  • 5.12.1 PATENT PUBLICATION TRENDS FOR VENTILATORS
• 5.13 TRADE ANALYSIS
  • 5.13.1 EXPORT DATA FOR VENTILATORS (HS CODE 9018)
  • 5.13.2 IMPORT DATA FOR VENTILATORS (HS CODE 9018)
• 5.14 KEY CONFERENCES AND EVENTS, 2023-2024
• 5.15 REIMBURSEMENT SCENARIO
• 5.16 UNMET NEEDS AND END-USER EXPECTATIONS
  • 5.16.1 UNMET NEEDS IN VENTILATORS MARKET
  • 5.16.2 END-USER EXPECTATIONS IN VENTILATORS MARKET
• 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.18 INVESTMENT & FUNDING SCENARIO
• 5.19 ADJACENT MARKET ANALYSIS
  • 5.19.1 RESPIRATORY DIAGNOSTICS MARKET
  • 5.19.2 SLEEP APNEA DEVICES MARKET
• 5.20 IMPACT OF AI/GEN AI ON VENTILATORS MARKET
  • 5.20.1 INTRODUCTION
  • 5.20.2 FUTURE OF HEALTHCARE-BIG DATA AND AI
  • 5.20.3 KNOWLEDGE-BASED SYSTEMS FOR VENTILATION MANAGEMENT

6 VENTILATORS MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 INTENSIVE CARE VENTILATORS
  • 6.2.1 HIGH-END ICU VENTILATORS
    • 6.2.1.1 Rising healthcare expenditure and improving infrastructure in emerging economies to drive market
  • 6.2.2 MID-END ICU VENTILATORS
    • 6.2.2.1 Higher affordability and accessibility to drive market
  • 6.2.3 BASIC ICU VENTILATORS
    • 6.2.3.1 Growing use in ambulatory care centers to drive market
• 6.3 PORTABLE/TRANSPORTABLE VENTILATORS
  • 6.3.1 INCREASING DEMAND FOR COMPACT DEVICES FOR MECHANICAL VENTILATION TO DRIVE MARKET

7 VENTILATORS MARKET, BY AGE GROUP

• 7.1 INTRODUCTION
• 7.2 ADULT & PEDIATRIC VENTILATORS
  • 7.2.1 GROWING GERIATRIC POPULATION TO DRIVE MARKET
• 7.3 NEONATAL/INFANT VENTILATORS
  • 7.3.1 TECHNOLOGICAL ADVANCEMENTS IN NEONATAL MONITORS TO DRIVE MARKET

8 VENTILATION MARKET, BY INTERFACE

• 8.1 INTRODUCTION
• 8.2 HYBRID VENTILATION
  • 8.2.1 RISING PREVALENCE OF COPD & ARDS TO DRIVE MARKET
• 8.3 NON-INVASIVE VENTILATION
  • 8.3.1 RELIABILITY OF MECHANICAL DESIGNS TO DRIVE MARKET
• 8.4 INVASIVE VENTILATION
  • 8.4.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET

9 VENTILATORS MARKET, BY MODE

• 9.1 INTRODUCTION
• 9.2 COMBINED-MODE VENTILATORS
  • 9.2.1 COMBINED BENEFITS OF VOLUME-TARGETED AND PRESSURE-TARGETED VENTILATORS TO DRIVE MARKET
• 9.3 VOLUME-MODE VENTILATORS
  • 9.3.1 INCREASING DEMAND FOR ADVANCED RESPIRATORY SUPPORT SYSTEMS IN HEALTHCARE SETTINGS TO DRIVE MARKET
• 9.4 PRESSURE-MODE VENTILATORS
  • 9.4.1 PRESET INSPIRATORY PRESSURE MAINTENANCE AND BETTER PATIENT COMFORT TO DRIVE MARKET
• 9.5 OTHER VENTILATORS

10 VENTILATORS MARKET, BY CARE SETTING

• 10.1 INTRODUCTION
• 10.2 HOSPITALS & CLINICS
  • 10.2.1 RISING DEMAND FOR VENTILATORS IN PRIVATE HOSPITALS TO DRIVE MARKET
• 10.3 AMBULATORY CARE CENTERS
  • 10.3.1 INCREASING NUMBER OF OUTPATIENT VISITS TO DRIVE MARKET
• 10.4 EMERGENCY MEDICAL SERVICES
  • 10.4.1 HIGH INCIDENCE OF TRAUMA INJURIES TO DRIVE MARKET
• 10.5 HOME CARE SETTINGS
  • 10.5.1 EMERGENCE OF REMOTE PATIENT MONITORING DEVICES TO DRIVE MARKET

11 VENTILATORS MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 High prevalence of COPD to drive the market
  • 11.2.3 CANADA
    • 11.2.3.1 Increasing incidence of asthma to drive market
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 Rising healthcare spending to increase demand for high-end ventilators
  • 11.3.3 FRANCE
    • 11.3.3.1 Highly advanced healthcare system to drive adoption of ventilators in hospitals
  • 11.3.4 UK
    • 11.3.4.1 Increasing healthcare expenditure to drive market growth
  • 11.3.5 ITALY
    • 11.3.5.1 High growth in geriatric population and subsequent rise in age-related respiratory diseases to drive market
  • 11.3.6 SPAIN
    • 11.3.6.1 High burden on state-run health insurance system and poor healthcare infrastructure to restrain market growth
  • 11.3.7 NETHERLANDS
    • 11.3.7.1 Rising prevalence of respiratory diseases to drive market
  • 11.3.8 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 JAPAN
    • 11.4.2.1 Established healthcare system to increase adoption of respiratory care devices
  • 11.4.3 CHINA
    • 11.4.3.1 High prevalence of COPD and lung cancer to propel demand
  • 11.4.4 INDIA
    • 11.4.4.1 Rising focus of global players on the Indian market to drive adoption of advanced ventilators
  • 11.4.5 AUSTRALIA
    • 11.4.5.1 High prevalence of chronic lung diseases to drive demand for ventilators
  • 11.4.6 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Healthcare infrastructure improvement to support market growth
  • 11.5.3 MEXICO
    • 11.5.3.1 Rising obesity rate to increase incidence rate of respiratory diseases
  • 11.5.4 ARGENTINA
    • 11.5.4.1 Incidence of severe acute respiratory infections to drive market
  • 11.5.5 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 RISING HEALTHCARE SPENDING AND PRESENCE OF MEDICAL DEVICE MANUFACTURING COMPANIES TO DRIVE MARKET
  • 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 11.7 GCC COUNTRIES
  • 11.7.1 HIGHER DISPOSABLE INCOME AND INCREASED GOVERNMENT HEALTHCARE EXPENDITURE TO PROPEL MARKET GROWTH
  • 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 2023
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VENTILATORS MARKET
• 12.3 REVENUE ANALYSIS, 2019-2023
• 12.4 MARKET SHARE ANALYSIS, 2023
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.5.5.1 Company footprint
    • 12.5.5.2 Region footprint
    • 12.5.5.3 Type footprint
    • 12.5.5.4 Age group footprint
    • 12.5.5.5 Interface footprint
    • 12.5.5.6 Mode footprint
    • 12.5.5.7 Care setting footprint
• 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 RESPONSIVE COMPANIES
  • 12.6.3 DYNAMIC COMPANIES
  • 12.6.4 STARTING BLOCKS
  • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 12.6.5.1 Detailed list of key startups/SMEs
    • 12.6.5.2 Competitive benchmarking of key startups/SMEs
• 12.7 VENTILATORS MARKET: R&D EXPENDITURE
• 12.8 COMPANY VALUATION & FINANCIAL METRICS
  • 12.8.1 FINANCIAL METRICS
  • 12.8.2 COMPANY VALUATION
• 12.9 BRAND/PRODUCT COMPARISON
• 12.10 COMPETITIVE SCENARIO
  • 12.10.1 PRODUCT LAUNCHES & APPROVALS
  • 12.10.2 DEALS
  • 12.10.3 OTHER DEVELOPMENTS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 RESMED
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product launches & approvals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 GETINGE AB
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches & approvals
      • 13.1.2.3.2 Other developments
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 KONINKLIJKE PHILIPS N.V.
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Other developments
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses and competitive threats
  • 13.1.4 DRAGERWERK AG & CO. KGAA
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product launches & approvals
      • 13.1.4.3.2 Deals
      • 13.1.4.3.3 Other developments
  • 13.1.5 ICU MEDICAL INC.
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Deals
  • 13.1.6 ASAHI KASEI CORPORATION
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Deals
  • 13.1.7 AIR LIQUIDE
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Deals
  • 13.1.8 FLEXICARE (GROUP) LIMITED
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Deals
  • 13.1.9 NIHON KOHDEN CORPORATION
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product launches
  • 13.1.10 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
  • 13.1.11 GE HEALTHCARE
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Deals
  • 13.1.12 BAXTER
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products offered
    • 13.1.12.3 Recent developments
      • 13.1.12.3.1 Deals
  • 13.1.13 VYAIRE MEDICAL, INC.
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Deals
      • 13.1.13.3.2 Other developments
  • 13.1.14 HAMILTON MEDICAL
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products offered
    • 13.1.14.3 Recent developments
      • 13.1.14.3.1 Product enhancements
• 13.2 OTHER PLAYERS
  • 13.2.1 SKANRAY TECHNOLOGIES, LTD.
  • 13.2.2 AXCENT MEDICAL GMBH
  • 13.2.3 METRAN CO., LTD.
  • 13.2.4 MAGNAMED
  • 13.2.5 LEISTUNG INGENIERIA SRL
  • 13.2.6 AVASARALA TECHNOLOGIES LIMITED
  • 13.2.7 AIRON CORPORATION
  • 13.2.8 TRITON ELECTRONIC SYSTEMS LTD.
  • 13.2.9 BIO-MED DEVICES, INC.
  • 13.2.10 HEYER MEDICAL AG
  • 13.2.11 AGVA HEALTHCARE
  • 13.2.12 BIODESIGN INNOVATION LABS
  • 13.2.13 NOCCARC ROBOTICS PVT LTD
  • 13.2.14 UMBULIZER
  • 13.2.15 SCHILLER HEALTHCARE INDIA PVT. LTD
  • 13.2.16 AVI HEALTHCARE

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS